» Articles » PMID: 11331083

Expression of the CAMP Response Element Binding Protein (CREB) in Hippocampus Produces an Antidepressant Effect

Overview
Journal Biol Psychiatry
Publisher Elsevier
Specialty Psychiatry
Date 2001 May 2
PMID 11331083
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recent studies have demonstrated that chronic antidepressant treatment increases the expression of the cyclic amp (cAMP) response element binding protein (CREB) in rat hippocampus. The study presented here was conducted to determine if CREB is a relevant target that produces an antidepressant-like effect.

Methods: We employed the herpes simplex virus (HSV)-mediated gene transfer technique to overexpress CREB and determined its effect on the learned helplessness and forced swim tests, two established models used for pharmacological screening of antidepressant drugs.

Results: In the learned helplessness model, rats that received bilateral microinjection of HSV-CREB into the dentate gyrus showed significantly fewer escape failures in the subsequent conditioned avoidance test than those injected with control vector (HSV-LacZ). In contrast, microinjection of HSV-CREB in either the CA1 pyramidal cell layer of hippocampus or the prefrontal cortex did not produce an antidepressant response. In the forced swim test, CREB expression in the dentate gyrus resulted in a significantly shorter immobility time than those injected with HSV-LacZ.

Conclusions: These results demonstrate that over-expression of CREB in hippocampus results in an antidepressant effect and suggest that CREB may serve as a potential molecular target for novel therapeutic agents.

Citing Articles

The crosstalk between CREB and PER2 mediates the transition between mania- and depression-like behavior.

Wang X, Ji Y, Li S, Serchov T Neuropsychopharmacology. 2025; .

PMID: 40011706 DOI: 10.1038/s41386-025-02076-5.


Empagliflozin-activated AMPK elicits neuroprotective properties in reserpine-induced depression via regulating dynamics of hippocampal autophagy/inflammation and PKCζ-mediated neurogenesis.

Muhammad R, Albahairy M, Abd El Fattah M, Ibrahim W Psychopharmacology (Berl). 2024; 241(12):2565-2584.

PMID: 39158617 PMC: 11569022. DOI: 10.1007/s00213-024-06663-0.


Functional Dimerization of Serotonin Receptors: Role in Health and Depressive Disorders.

Mitroshina E, Marasanova E, Vedunova M Int J Mol Sci. 2023; 24(22).

PMID: 38003611 PMC: 10671093. DOI: 10.3390/ijms242216416.


Correlation between variants of the CREB1 and GRM7 genes and risk of depression.

Wang L, Tang X, Liang P, Zhou C, Sun Y, Liang Y BMC Psychiatry. 2023; 23(1):3.

PMID: 36597080 PMC: 9811780. DOI: 10.1186/s12888-022-04458-1.


The Hallucinogenic Serotonin Receptor Agonist, 2,5-Dimethoxy-4-Iodoamphetamine, Promotes cAMP Response Element Binding Protein-Dependent Gene Expression of Specific Plasticity-Associated Genes in the Rodent Neocortex.

Desouza L, Benekareddy M, Fanibunda S, Mohammad F, Janakiraman B, Ghai U Front Mol Neurosci. 2022; 14:790213.

PMID: 35002622 PMC: 8739224. DOI: 10.3389/fnmol.2021.790213.